Recognition of a Gain on the Return of a Retirement Benefit Trust as an Extraordinary Gain in the Company's Non-Consolidated Financial Statements under Japanese GAAP
Sumitomo Pharma Co.,Ltd. (filing company)
Entire retirement benefit trust
The pension assets, including the retirement benefit trust assets, are overfunded relative to the retirement benefit obligation, and this condition is expected to continue. In addition, the Company will amortize in full the unrecognized actuarial differences arising from changes in the fair value of the shares contributed to the trust.
The Company expects to recognize a gain of approximately ¥17.3 billion on the return of the retirement benefit trust as an extraordinary gain (non-consolidated financial statements under Japanese GAAP).
Fiscal year ending March 2027 (1 April 2026 to 31 March 2027), in the non-consolidated financial statements under Japanese GAAP
The entire retirement benefit trust is scheduled to be returned on 28 September 2026. The amount of the gain on the return of the retirement benefit trust will be finalized when the return takes place and may therefore change. As the consolidated financial statements comply with IFRS, there will be no impact on consolidated profit or loss.
| Item | Details |
|---|---|
| Event name | Recognition of a Gain on the Return of a Retirement Benefit Trust as an Extraordinary Gain in the Company's Non-Consolidated Financial Statements under Japanese GAAP |
| Date of occurrence | 28 September 2026 (scheduled date for the return of the entire retirement benefit trust) |
| Subject Entity | Sumitomo Pharma Co.,Ltd. (filing company) |
| Target Locations / Products | Entire retirement benefit trust |
| Cause | The pension assets, including the retirement benefit trust assets, are overfunded relative to the retirement benefit obligation, and this condition is expected to continue. In addition, the Company will amortize in full the unrecognized actuarial differences arising from changes in the fair value of the shares contributed to the trust. |
| Amount of Impact on Business Performance | The Company expects to recognize a gain of approximately ¥17.3 billion on the return of the retirement benefit trust as an extraordinary gain (non-consolidated financial statements under Japanese GAAP). |
| Accounting period in which recognized | Fiscal year ending March 2027 (1 April 2026 to 31 March 2027), in the non-consolidated financial statements under Japanese GAAP |
| Outlook | The entire retirement benefit trust is scheduled to be returned on 28 September 2026. The amount of the gain on the return of the retirement benefit trust will be finalized when the return takes place and may therefore change. As the consolidated financial statements comply with IFRS, there will be no impact on consolidated profit or loss. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The pension assets, including the retirement benefit trust assets, are overfunded relative to the retirement benefit obligation, and this condition is expected to continue. In connection with the return, the Company will amortize in full the unrecognized actuarial differences arising from changes in the fair value of the shares contributed to the trust, resulting in the recognition of an extraordinary gain.